Please assess the completion status of the following clinical trial:

Trial Title: A Trial Comparing Efficacy of HM3 Versus F2 Lithotripters for Stone Fragmentation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients diagnosed with urolithiasis and choose to have ESWL treatment~2. Age 18-90 years old~3. Able to understand the informed consent~Exclusion Criteria:~1. Minors~2. Cognitively impaired

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Using HM3 lithotripter (Type: ACTIVE_COMPARATOR): This is an older generation lithotripter
- F2 lithotripter (Type: ACTIVE_COMPARATOR): This is a newer generation lithotripter

Based on this trial design, predict the completion outcome and termination type (if applicable).